Global Lubiprostone Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 277815
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Lubiprostone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Lubiprostone market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. CIC and OIC accounting for % of the Lubiprostone global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 8 mcg Capsules segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Lubiprostone include Takeda Pharmaceuticals, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Lubiprostone market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

8 mcg Capsules

24 mcg Capsules

Market segment by Application, can be divided into

CIC and OIC

IBS-C

Market segment by players, this report covers

Takeda Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Lubiprostone product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Lubiprostone, with revenue, gross margin and global market share of Lubiprostone from 2019 to 2022.

Chapter 3, the Lubiprostone competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Lubiprostone market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Lubiprostone research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Lubiprostone

1.2 Classification of Lubiprostone by Type

1.2.1 Overview: Global Lubiprostone Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Lubiprostone Revenue Market Share by Type in 2021

1.2.3 8 mcg Capsules

1.2.4 24 mcg Capsules

1.3 Global Lubiprostone Market by Application

1.3.1 Overview: Global Lubiprostone Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 CIC and OIC

1.3.3 IBS-C

1.4 Global Lubiprostone Market Size & Forecast

1.5 Global Lubiprostone Market Size and Forecast by Region

1.5.1 Global Lubiprostone Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Lubiprostone Market Size by Region, (2017-2022)

1.5.3 North America Lubiprostone Market Size and Prospect (2017-2028)

1.5.4 Europe Lubiprostone Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Lubiprostone Market Size and Prospect (2017-2028)

1.5.6 South America Lubiprostone Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Lubiprostone Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Lubiprostone Market Drivers

1.6.2 Lubiprostone Market Restraints

1.6.3 Lubiprostone Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Takeda Pharmaceuticals

2.1.1 Takeda Pharmaceuticals Details

2.1.2 Takeda Pharmaceuticals Major Business

2.1.3 Takeda Pharmaceuticals Lubiprostone Product and Solutions

2.1.4 Takeda Pharmaceuticals Lubiprostone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Takeda Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Lubiprostone Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Lubiprostone Players Market Share in 2021

3.2.2 Top 10 Lubiprostone Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Lubiprostone Players Head Office, Products and Services Provided

3.4 Lubiprostone Mergers & Acquisitions

3.5 Lubiprostone New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Lubiprostone Revenue and Market Share by Type (2017-2022)

4.2 Global Lubiprostone Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Lubiprostone Revenue Market Share by Application (2017-2022)

5.2 Global Lubiprostone Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Lubiprostone Revenue by Type (2017-2028)

6.2 North America Lubiprostone Revenue by Application (2017-2028)

6.3 North America Lubiprostone Market Size by Country

6.3.1 North America Lubiprostone Revenue by Country (2017-2028)

6.3.2 United States Lubiprostone Market Size and Forecast (2017-2028)

6.3.3 Canada Lubiprostone Market Size and Forecast (2017-2028)

6.3.4 Mexico Lubiprostone Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Lubiprostone Revenue by Type (2017-2028)

7.2 Europe Lubiprostone Revenue by Application (2017-2028)

7.3 Europe Lubiprostone Market Size by Country

7.3.1 Europe Lubiprostone Revenue by Country (2017-2028)

7.3.2 Germany Lubiprostone Market Size and Forecast (2017-2028)

7.3.3 France Lubiprostone Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Lubiprostone Market Size and Forecast (2017-2028)

7.3.5 Russia Lubiprostone Market Size and Forecast (2017-2028)

7.3.6 Italy Lubiprostone Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Lubiprostone Revenue by Type (2017-2028)

8.2 Asia-Pacific Lubiprostone Revenue by Application (2017-2028)

8.3 Asia-Pacific Lubiprostone Market Size by Region

8.3.1 Asia-Pacific Lubiprostone Revenue by Region (2017-2028)

8.3.2 China Lubiprostone Market Size and Forecast (2017-2028)

8.3.3 Japan Lubiprostone Market Size and Forecast (2017-2028)

8.3.4 South Korea Lubiprostone Market Size and Forecast (2017-2028)

8.3.5 India Lubiprostone Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Lubiprostone Market Size and Forecast (2017-2028)

8.3.7 Australia Lubiprostone Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Lubiprostone Revenue by Type (2017-2028)

9.2 South America Lubiprostone Revenue by Application (2017-2028)

9.3 South America Lubiprostone Market Size by Country

9.3.1 South America Lubiprostone Revenue by Country (2017-2028)

9.3.2 Brazil Lubiprostone Market Size and Forecast (2017-2028)

9.3.3 Argentina Lubiprostone Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Lubiprostone Revenue by Type (2017-2028)

10.2 Middle East & Africa Lubiprostone Revenue by Application (2017-2028)

10.3 Middle East & Africa Lubiprostone Market Size by Country

10.3.1 Middle East & Africa Lubiprostone Revenue by Country (2017-2028)

10.3.2 Turkey Lubiprostone Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Lubiprostone Market Size and Forecast (2017-2028)

10.3.4 UAE Lubiprostone Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Lubiprostone Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Lubiprostone Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Lubiprostone Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Lubiprostone Revenue (USD Million) by Region (2017-2022)

Table 5. Global Lubiprostone Revenue Market Share by Region (2023-2028)

Table 6. Takeda Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 7. Takeda Pharmaceuticals Major Business

Table 8. Takeda Pharmaceuticals Lubiprostone Product and Solutions

Table 9. Takeda Pharmaceuticals Lubiprostone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Global Lubiprostone Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 11. Global Lubiprostone Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 12. Breakdown of Lubiprostone by Company Type (Tier 1, Tier 2 and Tier 3)

Table 13. Lubiprostone Players Head Office, Products and Services Provided

Table 14. Lubiprostone Mergers & Acquisitions in the Past Five Years

Table 15. Lubiprostone New Entrants and Expansion Plans

Table 16. Global Lubiprostone Revenue (USD Million) by Type (2017-2022)

Table 17. Global Lubiprostone Revenue Share by Type (2017-2022)

Table 18. Global Lubiprostone Revenue Forecast by Type (2023-2028)

Table 19. Global Lubiprostone Revenue by Application (2017-2022)

Table 20. Global Lubiprostone Revenue Forecast by Application (2023-2028)

Table 21. North America Lubiprostone Revenue by Type (2017-2022) & (USD Million)

Table 22. North America Lubiprostone Revenue by Type (2023-2028) & (USD Million)

Table 23. North America Lubiprostone Revenue by Application (2017-2022) & (USD Million)

Table 24. North America Lubiprostone Revenue by Application (2023-2028) & (USD Million)

Table 25. North America Lubiprostone Revenue by Country (2017-2022) & (USD Million)

Table 26. North America Lubiprostone Revenue by Country (2023-2028) & (USD Million)

Table 27. Europe Lubiprostone Revenue by Type (2017-2022) & (USD Million)

Table 28. Europe Lubiprostone Revenue by Type (2023-2028) & (USD Million)

Table 29. Europe Lubiprostone Revenue by Application (2017-2022) & (USD Million)

Table 30. Europe Lubiprostone Revenue by Application (2023-2028) & (USD Million)

Table 31. Europe Lubiprostone Revenue by Country (2017-2022) & (USD Million)

Table 32. Europe Lubiprostone Revenue by Country (2023-2028) & (USD Million)

Table 33. Asia-Pacific Lubiprostone Revenue by Type (2017-2022) & (USD Million)

Table 34. Asia-Pacific Lubiprostone Revenue by Type (2023-2028) & (USD Million)

Table 35. Asia-Pacific Lubiprostone Revenue by Application (2017-2022) & (USD Million)

Table 36. Asia-Pacific Lubiprostone Revenue by Application (2023-2028) & (USD Million)

Table 37. Asia-Pacific Lubiprostone Revenue by Region (2017-2022) & (USD Million)

Table 38. Asia-Pacific Lubiprostone Revenue by Region (2023-2028) & (USD Million)

Table 39. South America Lubiprostone Revenue by Type (2017-2022) & (USD Million)

Table 40. South America Lubiprostone Revenue by Type (2023-2028) & (USD Million)

Table 41. South America Lubiprostone Revenue by Application (2017-2022) & (USD Million)

Table 42. South America Lubiprostone Revenue by Application (2023-2028) & (USD Million)

Table 43. South America Lubiprostone Revenue by Country (2017-2022) & (USD Million)

Table 44. South America Lubiprostone Revenue by Country (2023-2028) & (USD Million)

Table 45. Middle East & Africa Lubiprostone Revenue by Type (2017-2022) & (USD Million)

Table 46. Middle East & Africa Lubiprostone Revenue by Type (2023-2028) & (USD Million)

Table 47. Middle East & Africa Lubiprostone Revenue by Application (2017-2022) & (USD Million)

Table 48. Middle East & Africa Lubiprostone Revenue by Application (2023-2028) & (USD Million)

Table 49. Middle East & Africa Lubiprostone Revenue by Country (2017-2022) & (USD Million)

Table 50. Middle East & Africa Lubiprostone Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Lubiprostone Picture

Figure 2. Global Lubiprostone Revenue Market Share by Type in 2021

Figure 3. 8 mcg Capsules

Figure 4. 24 mcg Capsules

Figure 5. Lubiprostone Revenue Market Share by Application in 2021

Figure 6. CIC and OIC Picture

Figure 7. IBS-C Picture

Figure 8. Global Lubiprostone Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 9. Global Lubiprostone Revenue and Forecast (2017-2028) & (USD Million)

Figure 10. Global Lubiprostone Revenue Market Share by Region (2017-2028)

Figure 11. Global Lubiprostone Revenue Market Share by Region in 2021

Figure 12. North America Lubiprostone Revenue (USD Million) and Growth Rate (2017-2028)

Figure 13. Europe Lubiprostone Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Asia-Pacific Lubiprostone Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. South America Lubiprostone Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Middle East and Africa Lubiprostone Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Lubiprostone Market Drivers

Figure 18. Lubiprostone Market Restraints

Figure 19. Lubiprostone Market Trends

Figure 20. Takeda Pharmaceuticals Recent Developments and Future Plans

Figure 21. Global Lubiprostone Revenue Share by Players in 2021

Figure 22. Lubiprostone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 23. Global Top 3 Players Lubiprostone Revenue Market Share in 2021

Figure 24. Global Top 10 Players Lubiprostone Revenue Market Share in 2021

Figure 25. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 26. Global Lubiprostone Revenue Share by Type in 2021

Figure 27. Global Lubiprostone Market Share Forecast by Type (2023-2028)

Figure 28. Global Lubiprostone Revenue Share by Application in 2021

Figure 29. Global Lubiprostone Market Share Forecast by Application (2023-2028)

Figure 30. North America Lubiprostone Sales Market Share by Type (2017-2028)

Figure 31. North America Lubiprostone Sales Market Share by Application (2017-2028)

Figure 32. North America Lubiprostone Revenue Market Share by Country (2017-2028)

Figure 33. United States Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 34. Canada Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 35. Mexico Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 36. Europe Lubiprostone Sales Market Share by Type (2017-2028)

Figure 37. Europe Lubiprostone Sales Market Share by Application (2017-2028)

Figure 38. Europe Lubiprostone Revenue Market Share by Country (2017-2028)

Figure 39. Germany Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. France Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. United Kingdom Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Russia Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Italy Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Asia-Pacific Lubiprostone Sales Market Share by Type (2017-2028)

Figure 45. Asia-Pacific Lubiprostone Sales Market Share by Application (2017-2028)

Figure 46. Asia-Pacific Lubiprostone Revenue Market Share by Region (2017-2028)

Figure 47. China Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Japan Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. South Korea Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. India Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Southeast Asia Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Australia Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. South America Lubiprostone Sales Market Share by Type (2017-2028)

Figure 54. South America Lubiprostone Sales Market Share by Application (2017-2028)

Figure 55. South America Lubiprostone Revenue Market Share by Country (2017-2028)

Figure 56. Brazil Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Argentina Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Middle East and Africa Lubiprostone Sales Market Share by Type (2017-2028)

Figure 59. Middle East and Africa Lubiprostone Sales Market Share by Application (2017-2028)

Figure 60. Middle East and Africa Lubiprostone Revenue Market Share by Country (2017-2028)

Figure 61. Turkey Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Saudi Arabia Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. UAE Lubiprostone Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Methodology

Figure 65. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz